SPYRE THERAPEUTICS, INC. Gain (Loss) on Derivative Instruments, Net, Pretax
SPYRE THERAPEUTICS, INC. (SYRE) reported Gain (Loss) on Derivative Instruments, Net, Pretax of -$34.87 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2026-08-04
- SPYRE THERAPEUTICS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2026-06-30 was -$4.60M.
- SPYRE THERAPEUTICS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2026-03-31 was -$30.27M, a 1361.25% decline year-over-year.
- SPYRE THERAPEUTICS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2025-09-30 was $40.40M.
- SPYRE THERAPEUTICS, INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2025-06-30 was -$600.00K.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month |
|---|---|---|---|
| 2026-06-30 | -$4.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$34.87M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | -$30.27M 10-Q · filed 2026-05-05 | ||
| 2025-09-30 | $40.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $39.80M derived: sum of 2 quarters · filed 2026-08-04 | $42.20M 10-Q · filed 2025-11-04 |
| 2025-06-30 | -$600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $1.80M 10-Q · filed 2026-08-04 | |
| 2025-03-31 | $2.40M 10-Q · filed 2026-05-05 | ||
| 2024-09-30 | -$18.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$19.20M derived: sum of 2 quarters · filed 2025-11-04 | -$19.63M 10-Q · filed 2025-11-04 |
| 2024-06-30 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$930.00K 10-Q · filed 2025-08-05 | |
| 2024-03-31 | -$430.00K 10-Q · filed 2025-05-08 | ||
| 2023-03-31 | $0.00 10-Q/A · filed 2024-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |